Extensior 0.5mg Injection Combipack

Extensior 0.5 mg Injection Combipack – Semaglutide for Type 2 Diabetes Management

Extensior 0.5 mg Injection Combipack is a prescription injectable medicine containing Semaglutide 0.5 mg per dose. It is used alongside diet and physical activity to improve blood-sugar control in adults with insufficiently controlled type 2 diabetes mellitus. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps increase insulin release when blood glucose is elevated, reduces excess glucagon secretion, and slows the movement of food from the stomach. Each 1.5 mL multidose pre-filled pen contains a total of 2 mg semaglutide and provides four fixed doses of 0.5 mg. The combipack includes one pre-filled pen and four disposable needles.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 0.5 mg Per Dose: Each prescribed injection delivers 0.5 mg of semaglutide.
• Four-Dose Pen: Each multidose pen provides four fixed weekly doses.
• Supports Blood-Sugar Control: Helps lower elevated glucose levels in adults with type 2 diabetes.
• Once-Weekly Administration: Designed for use on the same day each week.
• FlexTouch Pre-Filled Pen: Allows accurate dose selection and subcutaneous administration.
• Prescription Medicine: Must be used according to a healthcare professional’s treatment plan.

Active Ingredient

• Semaglutide 0.5 mg per dose: A GLP-1 receptor agonist that supports glucose-dependent insulin release, reduces inappropriate glucagon secretion, and slows gastric emptying.

Uses

• Improvement of blood-sugar control in adults with type 2 diabetes mellitus.
• Used alongside an appropriate diet and regular physical activity.
• May be prescribed alone when metformin is unsuitable.
• May be prescribed with other diabetes medicines when additional glucose control is required.
• Supports reduction of HbA1c as part of a medically supervised diabetes-management plan.

How to Use

• Inject the prescribed dose once weekly on the same day each week.
• It may be administered at any time of the day, with or without meals.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with each weekly administration.
• Attach a new compatible disposable needle before every injection.
• Check that the solution is clear and colourless or almost colourless before use.
• Select only the prescribed 0.5 mg dose using the dose counter and pointer.
• Remove and safely discard the needle immediately after every injection.

Precautions

• Seek urgent medical attention for severe, persistent abdominal pain, particularly when accompanied by vomiting.
• Nausea, vomiting, and diarrhoea may cause dehydration and may affect kidney function.
• The risk of low blood sugar may increase when used with insulin or sulfonylurea medicines.
• Inform your doctor if you have pancreatitis, severe digestive problems, gastroparesis, kidney disease, or diabetic retinopathy.
• Report sudden or significant changes in vision promptly.
• Do not combine it with another semaglutide product or GLP-1 receptor agonist unless specifically prescribed.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or acid reflux.
• Abdominal bloating or increased gas.
• Reduced appetite.
• Dizziness or fatigue.
• Injection-site reactions.
• Low blood sugar when combined with certain diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Before first use, store in a refrigerator between 2°C and 8°C.
• Keep the pen away from the refrigerator’s cooling element.
• Do not freeze or use a pen that has been frozen.
• Keep the pen cap attached to protect the medicine from light.
• During use, the pen may be stored below 30°C or refrigerated between 2°C and 8°C for up to six weeks.
• Do not store the pen with a needle attached.
• Do not use the solution if it is cloudy, coloured, or contains visible particles.
• Discard the pen according to the supplied instructions after the four prescribed doses have been used.
• Keep out of the sight and reach of children.

Legal Disclaimer: Extensior 0.5 mg Injection Combipack is a prescription semaglutide medicine intended for adults with type 2 diabetes mellitus. The dose, concurrent diabetes medicines, treatment duration, and continued use must be determined by a qualified healthcare professional. This product should not be advertised as a guaranteed weight-loss treatment. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the official instructions supplied with the medicine.